The mechanistic relationship of phosphorylation of the C terminus of IKK␤ with phosphorylation of its T-loop kinase domain within the IKK complex remained unclear. We investigated the regulatory role of the serine cluster residing immediately adjacent to the HLH domain and of the serines in the NEMO/IKK␥-binding domain (NBD/␥BD) in the C-terminal portion of IKK␤ in MEFs deficient in IKK␤ and IKK␣ and in yeast reconstitution system. We show that phosphorylation events at the C terminus of IKK␤ can be divided into autophosphorylation of the serine cluster adjacent to the HLH domain and phosphorylation of the NBD/␥BD. Autophosphorylation of the serine cluster occurs immediately after IKK activation and requires IKK␥. In MEFs, this autophosphorylation does not have the down-regulatory function on the IKK complex that was previously described (1). On the other hand, phosphorylation of the NBD/␥BD regulates IKK␥-dependent phosphorylation of the T-loop activation domain in IKK␤ and, hence, IKK complex activation. Our study suggests that, within the IKK complex, modulation of the NBD/␥BD by IKK␥ is upstream to the T-loop phosphorylation.
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Phosphorylation of inhibitors of B (IB)
3 is catalyzed by the 700 -900-kDa enzyme complex IB kinase (IKK) (2) (3) (4) . IKK is composed of two homologous catalytic subunits IKK␣ and IKK␤ (85 and 87 kDa, respectively), and an unrelated regulatory 52-kDa subunit IKK␥ (5) also known as NEMO (NF-B essential modulator) (6) . IKK␥ is required for the stimulation of IKK by upstream signals such as TNF, Tax, lipopolysaccharide, and interleukin 1 (5, 6) .
IBs regulate the activity of the NF-B transcription factors. NF-Bs control the transcription of hundreds of genes involved in immunity, stress, and regulation of apoptosis and cellular proliferation. In resting cells, most NF-B dimers are bound to inhibitory IB proteins and sequestered in the cytoplasm (7) . Diverse stimuli, including cytokines, bacterial and viral products, oxidants, and mitogens lead to activation of IKK, which phosphorylates two regulatory serine residues on IBs (8) . This phosphorylation leads to recognition by the protein, ␤-TrCP, and to polyubiquitination by a specific ubiquitin ligase (9, 10) . After ubiquitination, the IB proteins are rapidly degraded by the proteasome.
This frees NF-B, which migrates to the nucleus where it binds to and stimulates the transcription of target genes (7) .
IKK complexes are composed of equal numbers of catalytic subunits (IKK␣ and/or ␤) and regulatory ␥ subunits (11) . IKK␣ and IKK␤ have similar structures including kinase domains and canonical mitogenactivated protein kinase activation loops (T-loops) toward their N termini (3) . In addition, IKK␣ and IKK␤ contain leucine zipper motifs through which the catalytic subunits associate (12) and helix-loop-helix domains toward the C terminus (4) . An ␣-helical region near the N terminus of IKK␥ binds to a 6-amino acid region (NEMO/␥-binding domain) at the very C terminus of IKK␣ and IKK␤, and interfering with this interaction diminishes stimulation of IKK by TNF␣ (13) .
Despite their structural similarities, IKK␣ and IKK␤ differ. IKK␤ is essential for the induction of NF-B by most proinflammatory stimuli whereas IKK␣ has roles in limb development, skin differentiation, B-cell maturation, and lymphoid organogenesis (14 -19) . Moreover, IKK␤ homodimer has approximately a 30-fold higher activity toward IB␣ than the IKK␣ homodimer (20) . Some of these differences may be attributed, in part, to an ubiquitin-like domain present in IKK␤ but not IKK␣. This domain is located between the kinase domain and leucine zipper of IKK␤, and its mutation or deletion causes loss of activity in IKK␤ (21) .
Like its substrate IB␣, IKK is regulated by phosphorylation and ubiquitination. TRAF6 (TNF receptor-associated factor 6) is essential for IKK signaling through the IL-1 receptor and Toll-like receptor (22) . TRAF6 contains a RING domain that acts as a ubiquitin ligase (23) . It undergoes trans-auto-ubiquitination (24) , and it also ubiquitinates IKK␥ (25) . Blocking ubiquitination prevents TRAF6-mediated activation of IKK (26) . Moreover, the T cell receptor appears to activate IKK via BCL10 and MALT1, which induce the ubiquitin ligase activity of TRAF6. RNA interference data indicate that TRAF2 and TRAF6 are required for IKK activation after T cell receptor ligation (25) . In addition, other signaling pathways that induce IKK activity including NOD2 (which serves as an intracellular signal for bacteria) and genotoxic stress, activate NF-B by ubiquitination of various lysine residues on IKK␥ (23, 27, 28) . IKK may be down-regulated by deubiquitinating proteases such as CYLD (the protein mutated in familial cylindromatosis), which associate with IKK␥ and deubiquitinate TRAF2 and TRAF6 (29 -31) .
All three subunits of IKK become phosphorylated within 10 min following treatment of HeLa cells with TNF, with concomitant stimulation of IKK activity (1) . IKK is inactivated by protein phosphatase 2a, indicating that it is activated by phosphorylation (2) . IKK can also be dephosphorylated by protein phosphatase PP2C␤, and it has been shown to associate with PP2C␤ with kinetics consistent with a role in down-regulating its activity (32) . Phosphopeptide mapping of IKK␤ indicates that phosphorylation occurs at serine residues in the T-loop (Ser 177 and Ser 181 ) and at a cluster of serines located between the HLH domain and the C terminus (1). Mutation of the T-loop serines of IKK␤ to alanines prevents IKK activation in mammalian cell lines, whereas conversion of these residues to glutamic acids makes the kinase constitutively active, indicating that the kinase is activated by phosphorylation of the T-loop (1, 3) . Phosphorylation of the T-loop of IKK␤, which occurs when IKK is activated, is followed by progressive phosphorylation of the cluster of serines at its C terminus (1). This phosphorylation was suggested to play a role in down-regulating the activity of IKK in HeLa cells (1) . A mutation mimicking phosphorylation in the NEMO/␥ binding domain (NBD/␥BD) of IKK␤ diminishes its ability to activate NF-B, suggesting that phosphorylation of this residue, in particular, may have regulatory significance (33) .
In this study, we investigated the regulatory role of the serine cluster residing immediately after the HLH domain and the serines in the NBD/ ␥BD in the C terminus of IKK␤ in MEFs deficient in IKK␤ and IKK␣ and in yeast reconstitution system. We show that phosphorylation events at the C terminus of IKK␤ can be divided into autophosphorylation of the serine cluster immediately following the HLH domain, and phosphorylation of the NBD/␥BD. Autophosphorylation of the serine cluster occurs immediately after IKK activation, and requires IKK␥. In MEFs, this autophosphorylation does not have the previously reported downregulatory function (1) . On the other hand, phosphorylation of the NBD/␥BD regulates IKK␥-dependent phosphorylation of the T-loop activation domain in IKK␤ and, hence, IKK complex activation. Our study puts regulation of the NBD/␥BD through IKK␥ upstream of the T-loop phosphorylation and IKK activation.
EXPERIMENTAL PROCEDURES
Cell Culture and Establishing Stable Pools of MEFs-Mouse embryonic fibroblasts (MEFs) deficient in IKK␤ (34) or IKK␣ and IKK␤ (35) were grown in Dulbecco's modified Eagle's medium, 10% fetal bovine serum with antibiotics and maintained at 37°C, 5% CO 2 . To establish stable pools of HA-tagged wild type and C-terminal serine to alanine mutants of IKK␤, corresponding plasmids (pRc-␤-actin), (1) carrying a neomycin resistance gene were transfected using Lipofectamine Plus TM (Invitrogen). Stable pools of MEFs for each construct were selected by growing cells in 2 mg/ml G418 sulfate (Cellgro, Mediatech, Inc.) for 6 weeks. Stable pools were maintained in 0.25 mg/ml G418 sulfate after the selection period. For experiments, 1.0 ϫ 10 6 cells were seeded in 60-mm dishes for 24 h, before treating with TNF␣ (20 ng/ml) or IL-1␤ (5 ng/ml) for the times indicated in the figures. Cells were harvested and the activities of IKK complexes were determined as described previously (4) .
Kinase Assays and Immunoblots-GST-IB␣-(1-54) was used as a substrate for IKK␤ because it contains the regulatory serines but lacks other residues that could be phosphorylated nonspecifically. It was expressed in bacteria and purified using glutathione-Sepharose beads (Amersham Biosciences).
Various peptides containing wild-type or mutant versions of the C terminus of IKK␤ were also produced so that they could be tested as possible substrates for IKK␤. Some of these peptides contain mutations in which serines were mutated to alanines, and all of these substrates spanned from the helix-loop-helix through the C terminus of IKK␤. DNA was amplified by polymerase chain reaction with full-length IKK␤ as template using Pfu Turbo (Stratagene, La Jolla, CA), digested, and inserted into the bacterial expression vector pET-HET-N1, which contains a Myc tag at the 5Ј-end and a His 6 tag at the 3Ј-end of the cloning site. DNA sequences of the constructs were verified by automated sequencing (Microchemical Core Facility/USC Norris Cancer Center). Plasmids were transformed into the bacterial strain BL21 and induced with isopropyl-1-thio-␤-D-galactopyranoside. The bacterial pellet from 500-ml culture was suspended in 50 ml of phosphate-buffered saline containing 6 M guanidine hydrochloride, sonicated for 3 min, frozen and thawed twice, and brought to a final concentration of 1% Triton X-100 and 5 mM ␤-mercaptoethanol. The lysate was cleared by centrifugation at 15,000 rpm for 30 min at 4°C and incubated with 1 ml of pre-equilibrated Ni-NTA superflow agarose (Qiagen) for 1 h at 4°C. Unbound proteins were washed away, and the bound proteins were renatured with a series of 50-ml buffers containing 4 M, 2 M, 1 M, 0.5 M, and 0 M urea in phosphate-buffered saline with 10 mM imidazole, 1% Triton X-100, and 5 mM ␤-mercaptoethanol. The IKK␤ peptides were eluted with 200 mM imidazole in 1-ml fractions, and the positive fractions were pooled and dialyzed in phosphate-buffered saline with 1 mM dithiothreitol and 10% glycerol.
For most kinase assays, purified human IKK␤ from Sf9 cells (12) , or gel filtration-purified or immunoprecipitated IKK complex from yeast was incubated for 30 min at 30°C in a 30-l reaction mixture containing 20 mM Tris, pH 7.6, 20 mM MgCl 2 , 20 M cold ATP, 2 mM dithiothreitol, [␥-32 P]ATP (ICN), and 2 g of protein substrate. The reactions were terminated by the addition of SDS-PAGE sample buffer and heated for 5 min at 97°C. Proteins were separated by SDS-PAGE and transferred to polyvinylidene difluoride (Bio-Rad), and labeling was detected by PhosphorImager (Molecular Dynamics).
For some experiments, IKK activity was tested using a range of IB␣ concentrations (from 4 -183 g/ml). The protocol was the same as above only the substrate concentration was varied, and the incubation time was shortened to 10 min.
Cloning and Expression of IKKs in Yeast-
The plasmid pESC-trpmet-HA-IKK␤ containing HA-IKK␤ under the methionine promoter was described previously (11) . To co-express similar levels of IKK␥ and IKK␤, HA-IKK␥ and its methionine promoter were inserted into the pESC-trp-met-HA-IKK␤ plasmid. Various point mutations were generated in IKK␤ by PCR using Pfu polymerase (Stratagene). These PCR products were digested and subcloned into the vectors pESC-trp-met-HA-IKK␤ and pESC-trp-met-HA-IKK␤ met-HA-IKK␥. The mutated regions were verified by sequencing. Plasmids were transformed into Saccharomyces cerevisiae strain YPH 499 (Stratagene) using lithium acetate as described (Stratagene pESC Yeast Epitope Tagging Vectors instruction manual).
2 ml of overnight cultures of yeast were grown in selective drop-out medium (Q-Biogene) containing 4 mM methionine (Q-Biogene) to suppress IKK expression and then expanded into 400 ml of selective noninducing medium. The yeast were grown at 30°C with shaking at 300 rpm before transfer to inducing medium (without methionine) and induced overnight (at 30°C with shaking). For harvesting and lysing the yeast, all steps were performed at 4°C unless otherwise indicated. They were first washed in 400 mM (NH 4 ) 2 SO 4 , 200 mM Tris-HCl, pH 8.0, 10 mM MgCl 2 , 10% glycerol, 2 mM p-nitrophenyl phosphate containing protease inhibitors (2.5 g/ml leupeptin, 20 g/ml aprotinin, 2.5 g/ml antipain, 2 g/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride, 0.1 g/ml chymostatin, and 1.1 g/ml phosphoramidon). The pellets were resuspended in an equal volume of lysis buffer (20 mM Tris, pH 7.6, 20 mM NaF, 20 mM ␤-glycerophosphate, 0.5 mM Na 3 VO 4 , 2.5 mM sodium metabisulfite, 5 mM benzamidine, 1 mM EDTA, 0.5 mM EGTA, 10% glycerol, 300 mM NaCl, 1% Triton X-100, 2 mM dithiothreitol, 2 mM p-nitrophenyl phosphate with protease inhibitors), transferred to yeast protein extraction vials (Q-Biogene), and frozen at Ϫ80°C. To lyse the yeast, the vials were thawed on ice, disrupted using a Q-Biogene FastPrep apparatus for 20 s on speed 6, and vortexed for 5 min. The vials were spun at 10,000 ϫ g, the supernatant was collected, and the pellets were resuspended in 0.67 ml of lysis buffer. The extraction procedure was repeated an additional three times. The combined supernatants were clarified by centrifugation for 3 min at 3000 ϫ g followed by ultracentrifugation for 1.5 h at 65,000 ϫ g. HA-IKK complex was then partially purified by gel filtration. 0.5 ml of extract (2-5 mg total protein) was loaded onto a Superose 6 gel filtration column (Amersham Biosciences) and samples were fractionated at a flow rate of 0.3 ml per minute. The gel filtration buffer contained 20 mM Tris, pH 7.6, 20 mM NaF, 20 mM ␤-glycerophosphate, 0.5 mM Na 3 VO 4 , 2.5 mM sodium metabisulfite, 5 mM benzamidine, 1 mM EDTA, 0.5 mM EGTA, 10% glycerol, 300 mM NaCl, and 0.1% Brij 35.
Alkaline Phosphatase Treatment-Approximately 6 g of yeast extract were immunoprecipitated using 1 l of anti-HA antibody (USC/ Norris core facility) in radioimmune precipitation assay buffer (20 mM Tris, pH 8.0, 1% deoxycholate, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 2 mM PNPP) followed by binding to protein G-Sepharose beads (Amersham Biosciences). Immune complexes were pelleted and washed once with radioimmune precipitation assay buffer and once with CIP buffer (calf intestinal phosphate buffer from New England BioLabs containing 0.1 mg/ml bovine serum albumin, 2.5 g/ml leupeptin, 20 g/ml aprotinin, 2.5 g/ml antipain, 2 g/ml pepstatin, 0.1 g/ml chymostatin, and 1.1 g/ml phosphoramidon). Pelleted proteins were then incubated for 15 min at 37°C in a 30-l reaction containing 10 units of calf intestinal phosphatase in CIP buffer. The alkaline phosphatase treatment was stopped by addition of SDS-PAGE sample buffer and heated for 5 min at 95°C. For untreated controls, the addition of calf intestinal phosphatase was omitted.
In Vivo Labeling-3.5-ml cultures of yeast were grown in selective medium containing 4 mM methionine to suppress IKK expression until they reached an optical density of 0.7-1.0. Then the yeast were pelleted and resuspended in 1 ml of selective medium without methionine (to induce IKK expression) and containing 1.4 mCi of [
32 P]orthophosphate. The yeast were radiolabeled and induced for 5 h, then washed with yeast wash buffer containing protease and phosphatase inhibitors, resuspended in 500 l of yeast lysis buffer containing protease and phosphatase inhibitors, and frozen at Ϫ80°C. The yeast were lysed as described above, and the extract was clarified by microcentrifugation for 1 min at 10,000 ϫ g followed by 20 min at 18,000 ϫ g.
To remove contaminating nonspecific immune complexes, the extracts were first immunoprecipitated with a nonspecific FLAG antibody (Sigma) and complexed to protein G-agarose (Amersham Biosciences). Then, HA-IKK was immunoprecipitated using monoclonal antibodies directed against HA (USC/Norris core facility) followed by binding to protein G-agarose. The beads were washed repeatedly in radioimmune precipitation assay buffer (20 mM Tris, pH 8.0, 1% deoxycholate, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 2 mM PNPP) before elution for 5 min at 97°C in SDS-PAGE loading buffer. The samples were electrophoresed using SDS-PAGE and transferred to polyvinylidene difluoride (Bio-Rad). Radiolabeling was detected by Phosphorimager. Blots were probed with anti-HA antibodies (USC/Norris Core Facility) followed by anti-mouse IgG horseradish peroxidase antibodies (Amersham Biosciences) and then detected by chemiluminescence (Pierce SuperSignal reagent) using a Bio-Rad Fluor-S Max quantification system.
Cyanogen Bromide (CNBr) Digestion-Yeast cells were 32 P-labeled and IKK was isolated as described above. For cyanogen bromide digestion, the immunoprecipitated samples were electrophoresed on an 8% SDS-PAGE gel. Autoradiography was used to locate the protein bands which were cut from the gel. The acrylamide slices were transferred to a siliconized tubed, crushed with a pipette, and resuspended in 200 l of 70% formic acid. Cyanogen bromide was added to a final concentration of 17 mg/ml, the samples were overlaid with argon gas, and digestion was allowed to proceed for 17 h at room temperature in the dark. Samples were microcentrifuged for 5 min, and the supernatants were transferred to siliconized tubes. The acrylamide was rinsed three times with 250 l of ddH2O, and the rinses were combined with the digested sample. The samples were dried overnight. The peptides were electrophoresed on a 16.5%T 3%C Tris Tricine gel and visualized using a PhosphorImager.
RESULTS

Mutating C-terminal Serine Residues to Alanine in IKK␤ Does Not
Alter Down-regulation of IKK Complex in MEFs-At least two regions of IKK␤ are phosphorylated on serine residues in response to stimulation. Phosphorylation of T-loop serines (177 and 181) in the kinase domain of IKK␤ are essential for IKK activation, and phosphorylation of at least ten serines (region spanning amino acid 664 to its end) in its C terminus was shown to play a role in down-regulation of IKK in HeLa cells in the background of endogenous IKK␤ (1). However, because a given IKK complex could contain 6 to 9 catalytic subunits (11), expression of mutated forms of IKK␣ or IKK␤ in mammalian cells could result in the formation of heterocomplexes containing endogenous wild-type along with mutated forms. For example, when kinase-defective mutants HA-IKK␣Km or HA-IKK␤KA were expressed in HeLa or HEK 293 cells, immunoprecipitation of the mutant kinases resulted in precipitation of very active and TNF-inducible IKK complexes (4). This clearly indicates that mutant IKK␣ or IKK␤ were incorporated into the endogenous IKK complexes. Considering this, changes seen in the kinetics of IKK regulation may have been due to the formation of heterocomplexes, when the activity of the C-terminal serine to alanine mutants of IKK␤ were tested in HeLa cells in the background of endogenous IKK␤ (1). Here we examined the activities of the same mutant IKK␤s used in Delhase and co-workers (34), in embryonic fibroblasts derived from IKK␤-deficient mouse (MEF␤ Ϫ/Ϫ ). We generated stable pools of MEF␤ Ϫ/Ϫ cells expressing either wild-type IKK␤, or M10, L3SA, or M12 mutants. In the M10 construct, 10 serines C-terminal to the helixloop-helix are mutated to alanines, whereas the last 4 serines remained unchanged, and in the M12 construct, these same 10 serines as well as Ser 740 and Ser 750 are mutated to alanines. IKK␤L3SA has three serines (Ser 733 , Ser 740 , and Ser 750 ) mutated to alanines. The activities of IKK complexes were determined by the immune kinase complex assay in these cells before and after treatment with TNF␣ for 5, 15, 30, 60, and 120 min. As shown in Fig. 1A , there is no obvious difference between the activation and down-regulation kinetics of IKK␤ wild type and IKK␤M10. The same is true for the IKK␤L3SA and IKK␤M12 mutants (Fig. 1A) . In all cases, the reconstituted IKK wild type or mutants show very little activity in untreated cells and reach peak activity at 15 min, similar to native IKK as previously reported (4) . The activity of wild type or mutated IKK␤ is down-regulated at 30 min and remains low up to 120 min (Fig. 1A) . The only major difference in IKK activity is that for the M12 and L3SA mutants (which contain mutations in the serines in the ␥BD) where IKK has faster activation kinetics (Fig. 1A) . This occurs independently of the mutations of the 10 preceding serines. The L3SA and M12 mutants show reasonably strong TNF-induced activity at 5 min (Fig. 1A) . These experiments were repeated several times and similar results were obtained (data not shown). Results in Fig. 1A indicate that the ten serines preceding the NBD/␥BD of IKK␤ do not play a role in down-regulating the activity of IKK complex. On the other hand, serines 733, 740, and 750 within and around the ␥-binding domain may play a role for IKK regulation (see below).
We further examined in vitro whether there is a difference in activities between wild-type IKK␤ and IKK␤M10 in the absence of IKK␣. IKK complexes containing IKK␥ with either wild-type IKK␤ or IKK␤M10 were expressed in yeast and partially purified by gel filtration. The activities were compared over a range of concentrations of IB␣ substrate (from 4 to 183 g/ml, Fig. 1B) . The activity of the IKK␤⌴10 was similar to the activity of wild-type IKK␤ over the whole range of substrate concentrations. This indicates that rendering the serines at the C terminus of IKK␤ unphosphorylatable neither increases nor decreases kinase activity toward IB␣. For this kinase assay, there was a 10 min. incubation of enzyme in the presence of substrates, and the level of IKK␤ seemed to be significantly lower at the end of the assay for samples incubated with low concentrations of IB␣ (compared with the level of IKK␤ after incubation in high concentrations of IB␣). This indicates that somehow, the higher concentrations of substrate stabilized the enzyme during the assay. Because of this, it was not possible to quantitatively compare the kinetic parameters of the wild-type IKK␤ to IKK␤M10 containing complexes. Nevertheless, qualitatively, both complexes show very similar activities.
The C Terminus of IKK␤ Is Autophosphorylated in Yeast in an IKK␥-dependent Manner-Previous work (1) suggested that the C terminus of IKK␤ becomes phosphorylated following IKK activation via autophosphorylation in mammalian cells. Here we used the IKK reconstituted in yeast to examine IKK␥-dependence of the autophosphorylation of the C terminus of IKK␤. A routine Western blot of IKKs expressed in yeast using HA antibodies revealed a pronounced band shift of IKK␤ when co-expressed with IKK␥ ( Fig. 2A) . This marked band shift induced by the presence of IKK␥ occurred for wild-type IKK␤ and IKK␤ ␥BD AA (a mutant of IKK in which serines 740 and 750 are changes to alanine, see also Fig. 3A ) but was not observed for the M10 and M12 mutants. This suggests that the serine residues C-terminal to the helix-loop-helix are phosphorylated. The greatly reduced band shift for M10 and M12, in which most of the C-terminal serines are rendered incapable of phosphorylation, suggests that much of the phosphorylation occurs in the 10 serines immediately C-terminal to the helix-loop-helix, and it requires IKK␥.
To confirm that the band shift seen in IKK␤ when co-expressed with IKK␥ was caused by phosphorylation, extracts were treated with alkaline phosphatase. IKK␤ co-expressed with IKK␥ migrates slower compared with IKK␤ (expressed alone) on SDS-PAGE (Fig. 2B, compare  lanes 1 and 3) . However, after treatment with alkaline phosphatase the IKK␤ expressed with IKK␥ migrates at the same rate as IKK␤ expressed alone (Fig. 2B, lane 4) , suggesting that the band shift was caused by phosphorylation. The migration of IKK␤M10 (with or without IKK␥) (Fig. 2B, lanes 5-8) was unaffected by the alkaline phosphatase treatment. This indicates that the extent of phosphorylation of IKK␤⌴10 mutant is significantly lower than wild-type IKK␤. It further indicates that much of the phosphorylation observed during co-expression of IKK␥ with IKK␤ must occur in the 10 serines immediately following the HLH domain.
The alkaline phosphatase experiment also indicates that IKK␥ is phosphorylated. IKK␥ is seen as a doublet when co-expressed with either IKK␤ or IKK␤M10; the size of the bands is similar for either complex. Treatment of IKK␤ϩ␥ or IKK␤M10ϩ␥ with alkaline phosphatase caused IKK␥ to migrate predominantly as the faster migrating band, indicating that the slower migrating band is phosphorylated.
To further demonstrate that the C terminus of IKK␤ is phosphorylated and the majority of the phosphorylation occurs on the ten serines between the HLH and the ␥BD, we labeled wild type, IKK␤-␥BDAA, and IKK␤M12 in yeast with [ 32 P]orthophosphate. Wild-type IKK␤ and IKK␤-␥BDAA were expressed with or without IKK␥, and IKK␤M12 was expressed with IKK␥ (Fig. 2C) . The IKK␤s were immunoprecipitated using HA antibodies, gel-purified, and cleaved by CNBr for phosphopeptide mapping as described (1) . As shown in Fig. 2C , top panel, similar levels of IKK␤s were immunoprecipitated. Wild-type and IKK␤-␥BDAA are phosphorylated weakly when expressed alone (Fig. 2C, middle panel) . Their level of phosphorylation increases significantly when expressed with IKK␥. The phosphorylation of the IKK␤M12 mutant in the presence of IKK␥ is low and similar to the levels of wild type IKK␤-␥BDAA in the absence of IKK␥ expression. When co-expressed with IKK␥, the C-terminal fragment of IKK␤, the 32 P-labeled peptide band above the 5-kDa marker is seen in the wild type and IKK␤-␥BDAA, but not in IKK␤M12 mutant (Fig. 2C, bottom panel) .
We further assessed whether IKK␤ purified from Sf9 cells is capable of phosphorylating a peptide containing the C-terminal serines of IKK␤ in trans. The entire C-terminal region of IKK␤ including the HLH, serine-rich, and the NBD/␥BDs were produced with a Myc tag and a His 6 tag at their C terminus in bacteria. For some of these peptides, ten or more of the serines were mutated to alanines. For M10, the first 10 serines after the HLH were substituted with alanine. For M12, twelve serines, including those in and near the NBD/␥BD, were substituted with alanine. For M14, 14 serines were substituted with alanine. These peptides were expressed in bacteria and purified using nickel beads. 4 As shown in Fig. 2D , purified IKK␤ was able to phosphorylate the peptide containing the wild type and the M10, M12, and M14 peptides. The mutant peptides were phosphorylated 3-5 times less efficiently than the wild-type peptide. As a control, purified IKK␤ strongly phosphorylated its known substrate IB␣. The phosphorylation of the C-terminal peptides by IKK␤ was significantly weaker than phosphorylation of the IB␣. The data indicate that IKK␤ can phosphorylate its C terminus. However, perhaps caused by the absence of IKK␥ and conformational requirements only present within the IKK complex, phosphorylation of the C-terminal serines may not be as specific and efficient in trans. Phosphorylation of M10, M12, and M14 in trans by IKK␤ could also occur on threonine residues in the C terminus of IKK␤. Taken together, data in Fig. 2 indicate that the C-terminal serines between HLH and NBD/␥BD in IKK␤ are autophosphorylated in an IKK␥-dependent manner.
IKK␥ Induces Phosphorylation of the T-loop of IKK␤ and Mimicks a Phosphorylation State of the NBD/␥BD That Reduces IKK Activation
Significantly-As shown above, autophosphorylation of ten serines between the HLH and NBD/␥BD of IKK␤ does not seem to play a role in regulating IKK complex activity. May et al. (33) suggested that phosphorylation of serines 740 in the NBD/␥BD may down-regulate IKK activity. We used the yeast reconstitution of IKK to examine whether mimicking the phosphorylation state of the serines 740 and 750 in the NBD/␥BD has a negative effect in IKK␥-induced activation of IKK complex. Substituting serine to glutamate to mimic a negative charge has resulted in constitutively active MAP kinases (36) . In the case of IKK kinases, phosphorylation of the regulatory serines in the T-loop activation region in the kinase domain has resulted in constitutive activity (3). We generated yeast expression vectors for HA-IKK␤-␥BDEE (in which serines 740, and 750 are mutated to glutamate) and HA-IKK␤-␥BDAA (in which serines 740 and 750 are mutated to alanine, see Fig. 3A ). We also generated yeast expression vectors for HA-IKK␤-T-loopEE, HA-IKK␤-T-loopAA, and HA-IKK␤-T-loopEE-␥BDEE (Fig. 3A) . Each IKK␤ was expressed alone or with IKK␥ on the same vector in yeast, and IKK complexes were partially purified by gel filtration. IKK␤ reconstituted with IKK␥ (Fig. 3B, lane 2) has higher activity than IKK␤ alone (Fig. 3B, lane 1) , indicating that IKK␥ facilitates self-activation of IKK. Mutating the T-loop regulatory serines to glutamate to mimic the phosphorylated state results in high activity (Fig. 3B, lane 3) , which is not further activated by co-expression with IKK␥ (Fig. 3B, lane 4) . This indicates that the regulatory role of IKK␥ is upstream of the phosphorylation of the T-loop serines. Mutation of the T-loop serines to alanines makes the kinase completely inactive (Fig. 3B, lane 5) , and this mutated IKK␤ T-loop AA cannot be activated at all by the presence of IKK␥ (lane 6). When the serines 740 and 750 in the NBD/␥BD are mutated to glutamate, IKK␤ still has a low level of kinase activity (Fig. 3B, lane 7) , similar to wild-type IKK␤ (Fig. 3B, lane 1) indicates that the analog of phosphorylated serines in the ␥BD prevents IKK␥ from facilitating self-activation of IKK and supports the hypothesis that phosphorylation of these amino acids is a mechanism to maintain IKK in a state of low level of activity. IKK␤ with the 6 amino acids in the NBD/␥BD domain at the C terminus (LDWSWL) deleted had a low level of activity (Fig. 3B, lane 9) , similar to wild-type IKK␤, but IKK␥ could not allow the complex to self-activate (Fig. 3B, lane 10) . This further indicates that the ␥BD is required for self-activation of the complex. IKK␤-␥BDAA, in which serines at the NBD/␥BD (740, 750) were mutated to alanine, had a similar level of IKK activity to wild type (Fig.  3B, lane 11) , and IKK␥ facilitates its self-activation (Fig. 3B, lane 12) similar to wild type. Finally, when both the T-loop serines and NBD/ ) and a series of serines following the HLH domain. These serines were mutated to alanines (to prevent possible phosphorylation) or to glutamic acids (to make them mimic the phosphorylated state). These constructs were transformed into and used to express full-length IKK␤ (with an HA tag at the N terminus) in yeast. B, kinase assay comparing activity of wild-type and mutant forms of IKK␤. Wild-type or mutant forms of HA-IKK␤ were expressed alone or co-expressed with HA-IKK␥ in yeast. Partially purified IKK complexes were tested for IKK kinase activity (KA), and the amounts of HA-IKK␤ and HA-IKK␥ were determined by anti-HA immunoblot (IB⅐anti-HA). C, phospholabeling of IKK␤ in yeast. Untransformed (YPD) yeast or yeast transformed with expression plasmids for various forms of IKK␤ (with or without IKK␥) were simultaneously induced and labeled with [ 32 P]orthophosphate. Yeast pellets were lysed, IKK was isolated by immunoprecipitation, and the level of autophosphorylation in IKK␤ was assessed by SDS-PAGE followed by PhosphorImager. D, scans from three independent experiments shown in C were quantified, and the data are shown as specific autophosphorylation of IKK␤. For each data point, the density of autophosphorylation was normalized based on the density of the corresponding signal in the immunoblot. The normalized autophosphorylation values of three independent experiments were averaged, and standard deviations were calculated.
␥BD serines are mutated to glutamate to mimic phosphorylation, IKK␤ has a high activity (Fig. 3B, lane 13) , and its activity is not further enhanced by the presence of IKK␥ (Fig. 3B, lane 14) . These results indicate that interaction of IKK␥ with the NBD/␥BD of IKK␤ is upstream to the phosphorylation of the T-loop serines, which can occur intramolecularly within the IKK complex.
Gel filtration analyses of the above complexes showed that IKK␤ containing point mutations in the NBD/␥BD form similar size complexes to the wild type and native IKK from HeLa cells (data not shown). This indicates that mutating serines to alanine or glutamate in the NBD/ ␥BD did not affect IKK complex formation.
To further confirm that mimicking the phosphorylation state of the ␥BD results in decreased IKK activity in vivo, we examined autophosphorylation of IKK␤ in yeast labeled with [ 32 P]orthophosphate. We compared the autophosphorylation of the wild-type, T-loop EE, and ␥BD EE IKK␤. Yeast were incubated in [ 32 P]orthophosphate for 5 h, induced to synthesize IKKs, harvested, and lysed, immunoprecipitated, separated by SDS-PAGE, and analyzed by autoradiography and Western blot. A representative experiment is shown in Fig. 3C and autophosphorylation data from three independent experiments were normalized based on the signal intensities of corresponding Western blots, and the results are shown in Fig. 3D . The wild-type IKK␤ expressed alone was only weakly autophosphorylated (Fig. 3, C and D) , but when co-expressed with IKK␥, the level of autophosphorylation increased by 2.3-fold. The IKK␤ T-loopEE (which has constitutively high activity toward IB␣, see Fig. 3B ) when expressed alone showed similar level of autophosphorylated to the wild type. The autophosphorylation of the T-loop EE increased by 3-fold when co-expressed with IKK␥. This result support the data in Fig. 2C that show IKK␥ facilitates increased phosphorylation of the C-terminal serines, even under conditions where its presence is not needed to activate IKK␤. The IKK␤ T-loopEE mutant cannot be phosphorylated in the T-loop, so this phosphorylation is most likely due to C-terminal phosphorylation, providing further support for the findings shown in Fig. 2 . The level of autophosphorylation in IKK␤-␥BDEE whose kinase activity toward IB␣ is low, even in the presence of IKK␥ (Fig. 3B) did not increase much when co-expressed with IKK␥ (Fig. 3, C and D) . In summary, these data suggest that IKK␥ facilitates the C-terminal phosphorylation of IKK␤ within the IKK complex. This is true even under conditions where IKK␤ is constitutively active. Furthermore, the data support the May et al. (33) findings in that phosphorylation of the NBD/␥BD in IKK␤ plays a regulatory role in IKK␥-dependent regulation of IKK complex.
Effect of the NBD/␥BD Mutations in IKK␤ on the Activity of Reconstituted IKK in MEF␣
Ϫ/Ϫ ␤ Ϫ/Ϫ -To investigate whether the data shown in expressing HA-tagged IKK␤-wt, IKK␤-␥BDEE, or IKK␤-␥BDAA were generated, and the activity of IKK complex was examined before and after treatment with IL-1␤ for 10 min (Fig. 4A) . Using anti-IKK␥ antibody, IKK␤⅐IKK␥ complexes were isolated and the kinase activity was assessed by immune kinase complex assay. The activity of IKK␤-wt was induced by IL-1␤ as expected (Fig. 4A) . The IKK␤-␥BDEE has a similar basal level of activity like the wild-type IKK, but its activity is not induced by IL-1␤ (Fig. 4A) . This is consistent with the yeast experiments in Fig. 3B , and supports the hypothesis that a negative charge(s) in the NBD/␥BD of IKK␤ can prevent induction of IKK. Preventing the phosphorylation of the serines in the NBD/␥BD should allow constitutive activity of the complex, at least to some degree. IKK␤-␥BDAA has significantly higher basal level kinase activity compared with the wild type, and this activity is only marginally induced by IL-1␤ (Fig. 4A) . It is important to note that in the presence of endogenous IKK␣ similar mutations in the NBD/␥BD of IKK␤ did not allow constitutive activity of the complex (see Fig. 1A ), though the activation was faster. This indicates that a wild-type NBD/␥BD in one of the kinase subunits within the IKK complex could be sufficient to allow IKK␥ to regulate the basal level of IKK complex.
To compare the in vivo activities of wild-type and mutant IKK␤s in the cell lines, we determined the phosphorylation of endogenous IB␣ using phospho-IB␣ antibodies before and after treatment with IL-1␤ for 5 and 10 min (Fig. 4B) . Because phosphorylated IB␣ is ubiquitinated and degraded rapidly, proteasome was inhibited by treating the cells with MG-132 (5 M) for 30 min prior to IL-1 treatment. The phospho-IB␣ antibody detects a background band that is present even in the cells transfected with vector. Treating cells with IL-1 did not increase the intensity of the background band in vector-transfected cells (Fig. 4B) . Because MEF␣ Ϫ/Ϫ ␤ Ϫ/Ϫ are devoid of any known IKK activity, the band detected by phospho-IB␣ antibody is most likely a weak interaction of this antibody with unphosphorylated IB␣. On the other hand, in cells expressing the wild-type IKK␤, phosphorylation of IB␣ increased significantly after IL-1 treatment (Fig. 4B) . In cells expressing IKK␤-␥BDEE, IL-1 treatment did not increase phosphorylation of IB␣ IKK␤-␥BDAA, and stable pools were selected using G418. The kinase activities of IKK was assessed by immune kinase complex assay using anti-IKK␥ antibodies in cells left untreated or treated with IL-1␤ for 10 min. Anti-IKK␥ antibody was used to isolate the IKK␤⅐IKK␥ complex. KA, kinase assay of the immunoprecipitated IKK toward GST-IB␣; IB, immunoblot using anti-HA to show that similar levels IKK␤ proteins were pulled-down in IKK complex. The HA-IKK amounts were determined by Western blot using anti-HA antibodies. B, IL-1-induced phosphorylation of the endogenous IB␣ was determined in cells described in A. To prevent rapid degradation of phosphorylated IB␣, cells were treated with 5 M MG-132 (a proteasome inhibitor) for 30 min prior treatment with IL-1␤ (2 ng/ml) for indicated times in minutes. For immunoblot analysis, 30 g of whole cell extracts were used. Levels of HA-IKK␤ was determined using anti-HA (top panel). Phosphorylated IB␣ was detected using the phospho-IB␣ (Ser 32 ) antibody (Cell Signaling) (middle panel). Total IB␣ protein levels was determined using an IB␣ antibody (Cell Signaling) (bottom panel). (Fig. 4B) . In cells expressing the IKK␤-␥BDAA and not treated with IL-1, phosphorylation of IB␣ is significantly higher than the wild-type IKK␤ (Fig. 4B) . Treatment of these cells with IL-1 did not increase phosphorylation of IB␣ further (Fig. 4B) .
Taken together, the data in Fig. 4 support the hypothesis that phosphorylation of the NBD/␥BD in IKK␤ and possibly in IKK␣ plays a role in regulation of the IKK complex.
DISCUSSION
There are at least 16 serine residues in IKK␤, which may be involved in up-regulating and down-regulating IKK activity. These consist of two serine residues in the T-loop and 14 serines following the HLH domain, including 2 serines in and adjacent to the NBD/␥BD. NIK activates IKK␣ by direct phosphorylation of T-loop serines (19) . However, many other stimuli activate IKK via IKK␥ and may not act by direct phosphorylation of T-loop serines. Rather many stimuli may act by altering the interaction of IKK␥ with the NBD/␥BD at the C terminus of IKK␤. As shown in Fig. 3B , when the serine residues in the NBD/␥BD of IKK␤ are mutated to resemble phosphoserine, the kinase is no longer stimulated by IKK␥ in the yeast reconstitution system. Expression of a similar IKK␤␥BDEE in MEF␣ Ϫ/Ϫ ␤ Ϫ/Ϫ could only be weakly stimulated by IL-1.
Furthermore, IKK␤␥〉⌬AA (where NBD/␥BD serines cannot be phosphorylated) was either constitutively active or showed more rapid activation kinetics than wild-type IKK. Altogether, these data suggest that phosphorylation of NBD/␥BD serines may be a mechanism by which IKK is maintained in a low activity state, and upstream stimuli may regulate IKK by altering the phosphorylation status of NBD/␥BD serines. Phosphorylation of serines in the region where IKK␥ binds to IKK␤ may alter the interaction between the two subunits, thereby altering its capacity to become activated. Data presented here and previously (33) indicate that phosphorylation of the NBD/␥BD maintains IKK in a basal state, but it is unclear what kinase is responsible for catalyzing this phosphorylation. The results of this study demonstrate that IKK␤ can phosphorylate a peptide substrate containing the serines in the NBD/␥BD of IKK␤, indicating that indeed IKK␤ can phosphorylate its NBD/␥BD. However, this phosphorylation is relatively weak (compared with the activity of IKK toward IB, see Fig. 2D ). Perhaps the level of phosphorylation observed is low because IKK␤ is phosphorylating exogenous C termini, and the kinase normally autophosphorylates its NBD/␥BD within the same complex. Perhaps this phosphorylation is weak because IKK␥ is needed for this autophosphorylation. Alternatively, it is possible that while IKK␤ can indeed autophosphorylate its NBD/␥BD, in mammalian cells there exists another kinase whose role is to phosphorylate the NBD/␥BD of IKK␤.
It is clear that phosphorylating the NBD/␥BD serines can diminish IKK activity, but these are not the only serines phosphorylated in the C terminus of IKK␤. As in mammalian cells, the 10 serines immediately following the HLH are heavily phosphorylated in the yeast reconstitution system. This study indicates that this is due to autophosphorylation, requires active IKK␤, and is strongly enhanced by IKK␥. Previous work using mammalian cells indicated that inactivating mutations in the kinase domain (K44A) or T-loop (S177A and S181A) of IKK␤ completely prevented IKK␤ phosphorylation at the C terminus, suggesting that the mechanism of C-terminal phosphorylation is autophosphorylation (1). However, it remained plausible that only native, active IKK could be recognizable by a putative exogenous IKK C-terminal kinase. Co-expression of IKK␥ with IKK␤ in the yeast system results in increased phosphorylation of IKK␤, primarily in the 10 serines immediately following the HLH as evidenced by direct in vivo labeling as well as by band shift during gel electrophoresis (Figs. 2 and 3 ). This result is not surprising since expression of IKK␥ is known to activate IKK␤, and IKK␤ has been shown to autophosphorylate its C terminus. However, when IKK␤ is made constitutively active by mutation of T-loop serines to glutamic acids, it is not phosphorylated very strongly. In contrast, when this same form of IKK␤ T-loop EE is co-expressed with IKK␥, a strong phosphorylation of the C terminus is seen. This result indicates that while having active kinase is sufficient for IKK␤ autophosphorylation, IKK␥ is somehow involved in augmenting the phosphorylation of C-terminal serines beyond the HLH. As shown in Fig. 1 , phosphorylation of these serines does not appear to affect IKK activity, nor does it appear to have a previously reported down-regulatory function (1) .
In studies involving mammalian cells, mutation of T-loop serines to glutamic acids resulted in constitutively high activity (1, 3) . However, because these cells have an NF-B activation pathway, it was possible that these phosphorylated residues attracted other molecules to the IKK complex, resulting in activation. Yeast cells lack the NF-B system (and presumably other factors involved in activating IKK). Nonetheless, when IKK␤ with phospho-mimicking residues in the T-loop is expressed in yeast (Fig. 3B) , it is constitutively active and does not require IKK␥. Mutation of the T-loop serines to alanines makes the kinase inactive, even in the presence of IKK␥. When both the NBD/␥BD serines and the T-loop serines were mutated to glutamic acids (Fig. 3B) , the kinase was constitutively active (with or without co-expression with IKK␥). This indicates that phosphorylation of the T-loop serines is the dominant factor governing whether IKK␤ is active or inactive; if the T-loop serines are phosphorylated, the kinase is not affected by changes in the phosphorylation status of the C terminus.
These data suggest that there are possibly dual mechanisms for activating IKK (see Fig. 5 ). Certain pathways (such as NIK) may activate IKK by directly phosphorylating the T-loop serines. Other stimuli may act via IKK␥ and the NBD/␥BD to cause conformational changes in the IKK complex, facilitating autophosphorylation of T-loop serines and increasing kinase activity. Phosphorylation of the NBD/␥BD serines may prevent IKK␥ from facilitating autophosphorylation and self-activation during periods of basal activity.
